EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients.
Saved in:
| Title: | EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients. |
|---|---|
| Authors: | Jittla P; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Graham DM; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Zhou C; CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK., Halliwell J; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., O'Reilly S; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Aruketty S; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Azizi A; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Germetaki T; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Lowe J; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Little M; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Punnett G; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK., McMahon P; Medical Oncology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK., Benson L; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Carter L; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Krebs MG; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Thistlethwaite FC; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Darlington E; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK., Yorke J; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK., Cook N; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: natalie.cook17@nhs.net. |
| Source: | ESMO open [ESMO Open] 2022 Oct; Vol. 7 (5), pp. 100550. Date of Electronic Publication: 2022 Aug 19. |
| Publication Type: | Observational Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35994790 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jittla+P%22">Jittla P</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Graham+DM%22">Graham DM</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Zhou+C%22">Zhou C</searchLink>; CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Halliwell+J%22">Halliwell J</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22O'Reilly+S%22">O'Reilly S</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Aruketty+S%22">Aruketty S</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Azizi+A%22">Azizi A</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Germetaki+T%22">Germetaki T</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lowe+J%22">Lowe J</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Little+M%22">Little M</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Punnett+G%22">Punnett G</searchLink>; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22McMahon+P%22">McMahon P</searchLink>; Medical Oncology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.<br /><searchLink fieldCode="AU" term="%22Benson+L%22">Benson L</searchLink>; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Carter+L%22">Carter L</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Krebs+MG%22">Krebs MG</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Thistlethwaite+FC%22">Thistlethwaite FC</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Darlington+E%22">Darlington E</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Yorke+J%22">Yorke J</searchLink>; Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Cook+N%22">Cook N</searchLink>; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address: natalie.cook17@nhs.net. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2022 Oct; Vol. 7 (5), pp. 100550. <i>Date of Electronic Publication: </i>2022 Aug 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Observational Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35994790 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.esmoop.2022.100550 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100550 Titles: – TitleFull: EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jittla P – PersonEntity: Name: NameFull: Graham DM – PersonEntity: Name: NameFull: Zhou C – PersonEntity: Name: NameFull: Halliwell J – PersonEntity: Name: NameFull: O'Reilly S – PersonEntity: Name: NameFull: Aruketty S – PersonEntity: Name: NameFull: Azizi A – PersonEntity: Name: NameFull: Germetaki T – PersonEntity: Name: NameFull: Lowe J – PersonEntity: Name: NameFull: Little M – PersonEntity: Name: NameFull: Punnett G – PersonEntity: Name: NameFull: McMahon P – PersonEntity: Name: NameFull: Benson L – PersonEntity: Name: NameFull: Carter L – PersonEntity: Name: NameFull: Krebs MG – PersonEntity: Name: NameFull: Thistlethwaite FC – PersonEntity: Name: NameFull: Darlington E – PersonEntity: Name: NameFull: Yorke J – PersonEntity: Name: NameFull: Cook N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2022 Oct Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2059-7029 Numbering: – Type: volume Value: 7 – Type: issue Value: 5 Titles: – TitleFull: ESMO open Type: main |
| ResultId | 1 |